| Literature DB >> 29636066 |
Yoko Azuma1, Hajime Otsuka1, Takashi Makino1, Satoshi Koezuka1, Yoichi Anami1, Sota Sadamoto2, Megumi Wakayama2, Naobumi Tochigi2, Kazutoshi Shibuya2, Akira Iyoda3.
Abstract
BACKGROUND: Some patients with thymoma present with a very large mass in the thoracic cavity. Although the most effective treatment for thymoma is surgical resection, it is difficult to perform because of the size of the tumor and the infiltration of tumor into the surrounding organs and vessels. We report a patient with a giant thymoma that was completely resected via a median sternotomy and left anterolateral thoracotomy. CASEEntities:
Keywords: Abbreviations; AchR acetylcholine receptor; Anterolateral thoracotomy; CT computed tomography; FDG-PET F18-fluorodeoxyglucose positron emission tomography; Giant thymoma; MG myasthenia gravis; Median sternotomy; WHO World Health Organization
Mesh:
Year: 2018 PMID: 29636066 PMCID: PMC5894157 DOI: 10.1186/s13019-018-0711-z
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1a Chest X-ray shows a very large mass in the left middle and lower lung fields. b Chest computed tomography shows a tumor (16 × 10 × 7 cm) in direct contact with a large area of the chest wall and diaphragm, and pressing on the heart and left upper pulmonary lobe
Fig. 2a Intraoperative view of the giant thymoma. The tumor was excised from the anterior mediastinal fat tissue and thymus, and occupied approximately half of the left pleural cavity. b The resected specimen was 16.5 × 11.8 × 7 cm in size
Fig. 3a Gross pathology of the tumor. The cut surface of tumor was colored red and yellowish, and appeared to be lobulated internally. b Histological findings of the tumor. The tumor was composed of a lymphocyte associated area and was diagnosed as a WHO type B2 thymoma with capsular invasion (Masaoka stage II)
Characteristics of patients with giant thymoma
| Author | Year | Age/Sex | Symptoms | Tumor size (cm) | Histology (WHO) | Masaoka Stage | Surgical Approach | Resection Completeness |
|---|---|---|---|---|---|---|---|---|
| Takanami [ | 1999 | 62 M | asymptom | 13 × 10 × 10 | A | I | median + right anterolateral | R0 |
| Santoprete [ | 2007 | 73 F | chest pain | 12 × 14 × 12 | AB | II | left clamshell | R0 |
| Yamazaki [ | 2007 | 58 F | palpitation | 20 × 14 × 8 | A | III | right anterolateral | R0 |
| Fazliogullari [ | 2012 | 28 M | dyspnea | 17 × 12 × 7 | AB | II | median | R1 |
| Takenaka [ | 2012 | 61 M | cough | 18 × 14 × 11 | AB | II | median | R0 |
| Filosso [ | 2012 | 74 F | dyspnea | 14 × 13 × 8 | AB | II | right posteroalateral | R0 |
| Spartails [ | 2012 | 83 F | kyphosis | 20 × 11 × 2 | B1 | I | median | R0 |
| Aydin [ | 2012 | 23 F | chest pain | 21 × 7 × 7 | B1 | II | right posteroalateral | R0 |
| Saito [ | 2015 | 45 M | asymptom | 13 × 10 | AB | I | right anterolateral | R0 |
| Zhao [ | 2016 | 46 M | dyspnea | 19 × 16 × 15 | AB | II | left hemic lamshell | R0 |
| Alexiev [ | 2016 | 49 F | cough | 10 < | AB | I | left anterolateral | R0 |
| Present case | 2017 | 63 F | asymptom | 16 × 10 × 7 | B2 | II | median + left anterolateral | R0 |